Clinical Study Report Writing at the Celesta Healthcare clinical research centre
Medical Writing · Clinical Study Reports

Clinical Study Report Writing

The CSR is the document a regulator actually reads. We write full and abbreviated clinical study reports in ICH E3 format — clear, internally consistent, and structured exactly the way the reviewing agency expects.

16
ICH E3 Sections
Covered
FDA · EMA
Submission-Ready
Formats
65+
Studies Behind
Our Writers
On Time
Committed
Delivery
Get a Proposal
All Medical Writing
Overview

The Document Your Study Becomes

Every screening visit, blood draw, and statistical output of a clinical study eventually condenses into one document: the clinical study report. Written to ICH E3 — the internationally harmonised 16-section format — the CSR is what reviewers at the US FDA, EMA, and DCGI actually read to judge what your study showed and whether the data hold up.

Two CSRs can describe the same dataset and produce very different reviews. A strong report keeps every number consistent from synopsis to appendix, explains protocol deviations before the reviewer asks about them, and presents efficacy and safety findings in the order and depth the guideline prescribes. A weak one generates queries — and every query cycle costs submission time.

Our writers sit beside the clinical, pharmacokinetic, and biostatistics teams that generate the data, backed by a division that has executed 65+ studies. We deliver full ICH E3 reports for patient trials, abbreviated CSRs and BA/BE study reports, and standalone CSR writing from sponsor-provided data packages — each aligned to the target agency from the first draft.

Clinical Study Report (CSR)

The complete, structured account of a clinical study — its design, conduct, statistical analysis, and results — prepared for regulatory review. It is the primary evidence document an agency reads when deciding what a study demonstrated.

ICH E3

The ICH guideline "Structure and Content of Clinical Study Reports" — a harmonised 16-section format accepted by the US FDA, EMA, DCGI, and other major agencies, so reviewers can find methods, populations, efficacy, and safety in the same place in every submission.

ICH E3 Structure

The Major Sections of an ICH E3 Clinical Study Report

ICH E3 prescribes a numbered 16-section outline. This is where each part of your study lives in the final report.

Major ICH E3 clinical study report sections and their contents
ICH E3 SectionWhat It Contains
1–2 · Title Page & SynopsisStudy identifiers, sponsor details, and a standalone summary of design, methods, and key results
5 · EthicsEthics committee approvals, ICH-GCP conduct statements, and informed consent procedures
6 · Investigators & Study StructureWho ran the study — investigators, sites, committees, and administrative responsibilities
7–8 · Introduction & ObjectivesProduct background, development context, and the precise study objectives
9 · Investigational PlanStudy design, endpoint definitions, treatments, blinding, randomization, and planned statistical methods
10 · Study PatientsParticipant disposition, protocol deviations, and analysis population definitions
11 · Efficacy EvaluationDatasets analysed, demographics and baseline data, and endpoint-by-endpoint efficacy results
12 · Safety EvaluationExtent of exposure, adverse events, deaths and serious events, laboratory values, and vital signs
13–15 · Discussion, Tables & ReferencesOverall conclusions, the cross-referenced summary tables and figures, and literature cited
16 · AppendicesProtocol and amendments, sample CRF, randomization scheme, data listings, and supporting documents
Inside Our Facility

Where This Work Happens

Writing and data operations workstations at the clinical research facility
Where CSRs Are Written — Data Operations Floor
How It Runs

CSR Writing Process

  1. 01

    Scope & Source Package

    Protocol, statistical analysis plan, tables-listings-figures, and target agency agreed — with the delivery timeline fixed against your database lock.

  2. 02

    Shell & Synopsis

    An ICH E3 shell tailored to the agency, with the synopsis drafted early so key messages are aligned before full writing begins.

  3. 03

    First Full Draft

    The complete report written from final outputs, with medical review for scientific accuracy and consistent interpretation.

  4. 04

    Review Cycles & Data QC

    Sponsor comments consolidated across rounds, and every in-text number checked against the source tables before each draft moves.

  5. 05

    Finalisation & Submission Support

    Appendices compiled, formatting made submission-ready, and the final CSR delivered with support through agency questions.

Why Celesta

Why Sponsors Choose Us for CSR Writing

  • Writers embedded with the clinical, PK, and biostatistics teams
  • Full ICH E3, abbreviated, and BA/BE study report formats
  • Backed by 70+ years of cumulative team experience
  • Every in-text number QC-checked against source tables
  • Structure and emphasis tailored to FDA, EMA, or DCGI review
  • On-time delivery commitments agreed per document, and kept
FAQs

CSR Writing — Frequently Asked Questions

1. What is ICH E3?
ICH E3 is the ICH guideline titled "Structure and Content of Clinical Study Reports". It defines a harmonised, numbered 16-section format for reporting a clinical study — from title page and synopsis through investigational plan, efficacy and safety evaluations, to appendices — so regulators worldwide can review studies consistently. The US FDA, EMA, and DCGI all accept CSRs in ICH E3 format.
2. What are the main sections of a clinical study report?
An ICH E3 CSR runs through 16 numbered sections: title page, synopsis, table of contents, abbreviations, ethics, investigators and study structure, introduction, objectives, the investigational plan, study patients, efficacy evaluation, safety evaluation, discussion and conclusions, reference tables and figures, a reference list, and appendices containing the protocol, listings, and supporting documents.
3. How long does it take to write a clinical study report?
The realistic driver is data readiness: serious writing starts once the final tables, listings, and figures are available after database lock. From there, a first full draft typically takes a matter of weeks, with total time depending on study size and sponsor review cycles. We agree a milestone timeline per document up front and plan the shell and synopsis before lock so no time is wasted.
4. Is a full CSR required for bioequivalence studies?
BA/BE study reports follow the ICH E3 structure, but agencies generally accept an abbreviated or adapted format because efficacy sections do not apply the way they do in patient trials. The pharmacokinetic, statistical, and bioanalytical reporting still needs to be complete and defensible. We write both full and abbreviated formats, matched to the target agency.
5. What is the difference between a CSR and a journal manuscript?
A CSR is the complete regulatory record of a study — every method, analysis, deviation, and safety finding, often running to hundreds of pages with appendices. A journal manuscript is a condensed scientific paper written for peer review, focused on the central findings. The CSR comes first; the manuscript is derived from it. Our team prepares both.
6. Can you write a CSR from another CRO’s study data?
Yes. Standalone CSR writing is a common request — we work from your protocol, statistical analysis plan, and final tables, listings, and figures, whoever generated them. The same ICH E3 discipline and data QC applies: every number in the text is verified against the source outputs before the draft reaches you.

More Medical Writing Services

Every study type under one roof — explore the rest of our medical writing capabilities.

Medical Writing Overview

Discuss Your CSR Writing Requirement

Share your molecule and target market — our scientific team responds with a study design, timeline, and detailed proposal within 24 business hours.

Need something? Chat with us!